Medical robotics innovator Noah Medical has raised $150 million in Series B funding. With participation from a number of well-known institutional and strategic investors, Noah Medical will use the funds to meet rising demand for the Galaxy System, its next-generation, integrated solution for navigated robotic bronchoscopy.

Led by the Softbank Vision Fund, and co-led by the Prosperity7 Ventures , the oversubscribed round also included investments from Tiger Global, and existing investors including Hillhouse, Sequoia China, Shangbay Capital, Uphonest Capital, Sunmed Capital, Lyfe Capital, 1955 Capital, AME cloud ventures, as well as undisclosed strategic investors.